Upgrade to SI Premium - Free Trial

Century Therapeutics (IPSC)

1.95 -0.05 (2.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 144 Century Therapeutics, Filed by: Russotti Gregory September 14, 2026 3:32 PM - SEC Filing Form 144 Century Therapeutics, Filed by: Carr Douglas September 14, 2026 3:29 PM - SEC Filing Form 4 Century Therapeutics, For: Sep 09 Filed by: Truitt Joseph September 10, 2026 5:49 PM - SEC Filing Form 3 Century Therapeutics, For: Sep 09 Filed by: Truitt Joseph September 10, 2026 5:48 PM - SEC Filing Century Therapeutics names Joseph Truitt to its board of directors September 9, 2026 4:05 PM - StreetInsider Century Therapeutics Appoints Joseph Truitt to Board of Directors September 9, 2026 4:05 PM - StreetInsider Form 4 Century Therapeutics, For: Aug 14 Filed by: Pfeiffenberger Brent August 18, 2026 4:18 PM - SEC Filing Form 8-K Century Therapeutics, For: Aug 12 August 12, 2026 8:12 AM - SEC Filing Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c August 12, 2026 8:03 AM - StreetInsider Form 10-Q Century Therapeutics, For: Jun 30 August 12, 2026 8:02 AM - SEC Filing Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates August 12, 2026 8:00 AM - StreetInsider Form 4 Century Therapeutics, For: Aug 03 Filed by: Carr Douglas August 5, 2026 4:12 PM - SEC Filing Century Therapeutics to present CNTY-813 preclinical data at two fall congresses July 9, 2026 8:00 AM - StreetInsider Century Therapeutics to present CNTY-813 preclinical data at two fall congresses July 9, 2026 8:00 AM - StreetInsider Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 July 9, 2026 8:00 AM - Globe NewsWire Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026 July 9, 2026 8:00 AM - StreetInsider Full Article List